~85 spots leftby Feb 2026

Peer Support & Storytelling for COPD

(ImPReSS-COPD Trial)

Recruiting in Palo Alto (17 mi)
PL
Overseen byPeter Lindenauer, MD, MSc
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Recruiting
Sponsor: Baystate Medical Center
Disqualifiers: Hospice, Long-term care, others
No Placebo Group

Trial Summary

What is the purpose of this trial?

Chronic Obstructive Pulmonary Disease (COPD) affects approximately 16 million Americans and is characterized by recurrent exacerbations that lead to 1.5 million Emergency Department visits and 700,000 hospitalizations annually. Pulmonary rehabilitation (PR) is a structured program of exercise and self-management support that has been proven to relieve shortness of breath and increase quality of life when initiated after an exacerbation, but unfortunately, few eligible patients participate. This project will compare the effectiveness of two novel strategies - one involving video narratives of other patients telling their story of how they overcame challenges and completed PR, the other involving telephonic peer coaching with an individual with lived experience - to enhanced usual care, and to each other, at increasing patient participation in PR after an exacerbation.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It seems focused on participation in pulmonary rehabilitation and peer support.

What data supports the effectiveness of the treatment Peer Support & Storytelling for COPD?

Research shows that phone-based peer coaching can reduce depressive symptoms and sleep disturbances in COPD patients, and narrative medicine helps improve the doctor-patient relationship, which can lead to better treatment adherence. These components suggest that storytelling and peer support may positively impact COPD management.12345

Is peer support and storytelling safe for use in clinical settings?

Research suggests that peer support and storytelling interventions are generally safe, as they focus on improving communication and engagement without involving medical procedures or drugs. These methods have been used to enhance safety in hospital settings and empower patients to participate in their care.678910

How does the Peer Support & Storytelling treatment for COPD differ from other treatments?

This treatment is unique because it focuses on peer support and storytelling to help manage COPD, rather than relying solely on medication or traditional therapies. It emphasizes the psychosocial aspects of living with COPD, aiming to improve quality of life through shared experiences and emotional support.12111213

Research Team

PL

Peter Lindenauer, MD, MSc

Principal Investigator

Baystate Health

Eligibility Criteria

This trial is for individuals over 40 with COPD who've been treated for an exacerbation and referred to pulmonary rehabilitation (PR). Participants must be willing to engage in peer coaching calls, watch storytelling videos, have a working phone, and communicate in English. Those not eligible or unwilling to attend PR, in hospice care, living in long-term facilities, or who have already completed significant PR are excluded.

Inclusion Criteria

I have been referred for lung rehab.
I have been treated for a COPD flare-up.
I am willing to engage in calls with a peer coach and watch videos.
See 3 more

Exclusion Criteria

I am not a candidate for pulmonary rehabilitation based on my lung function tests.
I am receiving care focused on comfort or am in hospice.
I am not willing to attend pulmonary rehabilitation.
See 3 more

Trial Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

R61 Phase

Recruit and train peer coaches, recruit storytellers, capture narratives on video, finalize protocol, trial infrastructure, and pilot recruitment strategy

Not specified

R33 Phase

Recruit 305 adults treated for exacerbation of COPD, randomize them to Enhanced Usual Care, eUC + Storytelling, or eUC + Peer Support, and evaluate effectiveness at promoting participation in PR at 6 months

6 months

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Treatment Details

Interventions

  • Storytelling (Behavioral Intervention)
  • Telephonic Peer Coaching (Behavioral Intervention)
Trial OverviewThe study tests two strategies aimed at increasing participation in PR post-exacerbation: video narratives from patients sharing their experiences with overcoming challenges related to PR and telephonic peer coaching by someone familiar with COPD. These methods will be compared against each other and enhanced usual care.
Participant Groups
3Treatment groups
Active Control
Group I: Enhanced usual care + Peer supportActive Control1 Intervention
Subjects randomized to the eUC + Peer support intervention will be matched with a peer coach of the same gender, race, and approximate age. For those enrolled during a hospitalization, coaches will be instructed to attempt the initial phone contact prior to the patient's discharge; for patients enrolled after an ED visit or outpatient exacerbation, coaches will be instructed to contact the patients within 72 hours of randomization. Peer coaches will be asked to complete at least one call each week during months 1-2, biweekly calls during months 3-4, and monthly calls during months 5-6. Coaches will be asked to follow a conversation guide, provided during the initial training, to structure phone conversations with their paired patient.
Group II: Enhanced usual careActive Control1 Intervention
Enhanced usual care describes a process in which automated surveillance is used to identify individuals experiencing a COPD exacerbation. This is followed by direct outreach - either through in-person visits while a patient is hospitalized, or by mail and telephone in the outpatient setting, to facilitate referral to PR. Subjects randomized to this arm will be given a pamphlet describing the benefits of PR.
Group III: Enhanced usual care + StorytellingActive Control1 Intervention
Subjects randomized to the eUC + Storytelling intervention will view the video narrative(s) of one or more individuals with COPD who has overcome similar barriers and has attended a program of PR. Subjects will be shown the first chapter of the story immediately after randomization and will receive email and/or text messages to prompt viewing of subsequent chapters at 2 weeks, 1 month, 2 months, 3 months and 5 months. Emails and text messages will include a link to a REDCap document that contains a set of embedded video clips representing the next chapter in each storyteller's narrative.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Baystate Medical Center

Lead Sponsor

Trials
67
Recruited
44,500+

Peter Banko

Baystate Medical Center

Chief Executive Officer

MBA from Stanford University

Dr. Yvonne Cheung

Baystate Medical Center

Chief Medical Officer since 2024

MD from Columbia University, MPH from Harvard School of Public Health, MBA from University of Massachusetts Amherst

University of Michigan

Collaborator

Trials
1,891
Recruited
6,458,000+

Marschall S. Runge

University of Michigan

Chief Executive Officer since 2015

MD, PhD

Karen McConnell profile image

Karen McConnell

University of Michigan

Chief Medical Officer since 2020

MD

University of Massachusetts, Worcester

Collaborator

Trials
372
Recruited
998,000+
Dr. Eric W. Dickson profile image

Dr. Eric W. Dickson

University of Massachusetts, Worcester

Chief Executive Officer since 2013

MD from UMass Chan Medical School, Master's in Health Care Management from Harvard University

Dr. Andy Karson profile image

Dr. Andy Karson

University of Massachusetts, Worcester

Chief Medical Officer

MD

COPD Foundation

Collaborator

Trials
18
Recruited
238,000+

National Heart, Lung, and Blood Institute (NHLBI)

Collaborator

Trials
3,987
Recruited
47,860,000+
Dr. Gary H. Gibbons profile image

Dr. Gary H. Gibbons

National Heart, Lung, and Blood Institute (NHLBI)

Chief Executive Officer since 2012

MD from Harvard Medical School

Dr. James P. Kiley profile image

Dr. James P. Kiley

National Heart, Lung, and Blood Institute (NHLBI)

Chief Medical Officer since 2011

MD from University of California, San Francisco

Findings from Research

In a study of 444 COPD patients, phone-based peer coaching did not significantly improve adherence to long-term oxygen therapy (LTOT) compared to usual care, with adherence rates of 74% in usual care, 84% in reactive coaching, and 70% in proactive coaching.
However, proactive coaching was associated with significant reductions in depressive symptoms and sleep disturbances compared to usual care, suggesting potential mental health benefits despite lower adherence rates.
A Hybrid Effectiveness/Implementation Clinical Trial of Adherence to Long-Term Oxygen Therapy for Chronic Obstructive Pulmonary Disease.Prieto-Centurion, V., Holm, KE., Casaburi, R., et al.[2023]
The use of an interactive phone telesystem significantly improved adherence to Written Action Plans in COPD patients, leading to faster recovery from exacerbations, as shown in a study involving 40 patients over one year.
A larger implementation of the telesystem with 256 patients resulted in a notable reduction in respiratory-related emergency room visits and COPD-related hospitalizations, indicating enhanced self-management and reduced healthcare utilization.
Innovating the treatment of COPD exacerbations: a phone interactive telesystem to increase COPD Action Plan adherence.Farias, R., Sedeno, M., Beaucage, D., et al.[2020]
A training project in narrative medicine for 74 pulmonologists revealed that 92% of COPD patients had activity limitations at their first visit, highlighting the impact of the disease on daily life.
The study found that a positive doctor-patient relationship significantly influences therapy adherence, with only 21% of patients able to resume activities when the relationship is strained, emphasizing the importance of effective communication in treatment.
Narrative medicine educational project to improve the care of patients with chronic obstructive pulmonary disease.Cappuccio, A., Sanduzzi Zamparelli, A., Verga, M., et al.[2022]

References

A Hybrid Effectiveness/Implementation Clinical Trial of Adherence to Long-Term Oxygen Therapy for Chronic Obstructive Pulmonary Disease. [2023]
Innovating the treatment of COPD exacerbations: a phone interactive telesystem to increase COPD Action Plan adherence. [2020]
Narrative medicine educational project to improve the care of patients with chronic obstructive pulmonary disease. [2022]
Intensive out-of-hospital coaching for frequently hospitalized COPD patients: a before-after feasibility study. [2023]
Patient education programs--can they improve outcomes in COPD? [2021]
Nature and type of patient-reported safety incidents in primary care: cross-sectional survey of patients from Australia and England. [2023]
How might health services capture patient-reported safety concerns in a hospital setting? An exploratory pilot study of three mechanisms. [2022]
Implementing an integrated in-situ coaching, observational audit, and story-telling intervention to support safe surgery. [2018]
Patient-Reported Outcome Measures in Safety Event Reporting: PROSPER Consortium guidance. [2022]
The Value of Patient-Peer Support in Improving Hospital Safety. [2021]
A case series of an off-the-shelf online health resource with integrated nurse coaching to support self-management in COPD. [2018]
12.United Statespubmed.ncbi.nlm.nih.gov
Acceptability of a peer-led self-management program for people living with chronic obstructive pulmonary disease in regional Southern Tasmania in Australia: A qualitative study. [2023]
Benefits Conferred by Peer-Support Nursing Intervention to Pulmonary Function and Quality of Life in Nonsmoking Patients with COPD. [2022]